Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies.

Authors:

Guidetti A, Dogliotti I, Chiappella A, Iannitto E, Evangelista A, Dodero A, Di Rocco A, Balzarotti M, Casadei B, Cavallo F, Re A, Farina M, Bramanti S, Chiusolo P, Martino M, Musso M, Zanni M, Grillo G, Ravano E, Krampera M, Hohaus S, Martelli M, Zacchi G, Visco C, Zinzani PL, Consoli U, Corradini P.

Source:

Haematologica

This website only uses technical cookies and does not collect personal data or use profiling cookies. By continuing to browse, you accept the use of cookies.